Merck clings to FDA, CDC endorsement in light of JAMA article In the wake of new safety data on Merck's human papillomavirus vaccine, both FDA and the Centers for Disease Control and Prevention have issued a statement supporting the product. "Based on the review of available … [Read more...] about FDA, CDC Continues Their Support of HPV Vaccine Gardasil
Gardasil
JAMA Declares Gardasil Safe, But Condems Ad Blitz
JAMA delivers mixed blessing to Merck The latest issue of JAMA delivered a mixed blessing to Merck's Gardasil. In a headliner study published by the Journal of the American Medical Association, the side effects of the human papillomavirus shot were deemed reasonable. Serious … [Read more...] about JAMA Declares Gardasil Safe, But Condems Ad Blitz
ICAP HPV Vaccine Papers Noted in Russian Media
I received an email from my ICAP associate, Christina England today. Her message explained a mystery I have been trying to solve for the past week. My site stats have indicated a large number of hits from Russian ISPs and those visitors spending time investigating my article … [Read more...] about ICAP HPV Vaccine Papers Noted in Russian Media
Merck & Co. Earnings Preview
Merck (MRK) is expected to report Q2 earnings Tuesday, July 21, before market open, with a conference call scheduled for 8:30 am ET. Guidance Analysts are looking for EPS of 77c on revenue of $5.84B. The consensus range is 75c-79c for EPS, and $5.70B-$5.98B for revenue, … [Read more...] about Merck & Co. Earnings Preview
WHO Appproves HPV Vaccine Cervarix For Poor Nations
World Health Organization' Endorsement Critical Win for Glaxo In a July 9th story, 'WHO clears Glaxo's Cervarix for developing world' Reuters reported that GlaxoSmithKline's (GSK.L) cervical cancer vaccine Cervarix has won a green light from the World Health Organisation (WHO) … [Read more...] about WHO Appproves HPV Vaccine Cervarix For Poor Nations